Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 151–200 of 18616
On July 22, 2026, the Board of Directors of National Health Investors, Inc. (the “Company”) appointed Christian Maingot, 56, as Chief Operations Officer of the Company, effective July 27, 2026.
On July 22, 2026, the Board of Directors appointed Mr. Kewei Huang as Co-Chief Executive Officer of the Company.
the Board appointed William B. Miller, the Company’s Chief Financial Officer, to also serve as Interim Principal Executive Officer
On July 23, 2026, James C. Kerr, Executive Vice President and Chief Financial Officer, informed The Gorman-Rupp Company (the “Company” or “Gorman-Rupp”) of his decision to retire from the Company.
Mr. Kerr will be succeeded as Chief Financial Officer by current Vice President of Finance, Ronald F. Stoops, effective October 1, 2026.
On July 22, 2026, Sidus Space, Inc. (the “Company”) appointed Alan Khalili as Chief Financial Officer, effective July 27, 2026.
On July 20, 2026, ImageneBio, Inc., a Delaware corporation (the “Company”), based in part on the recommendation of Kristin Yarema, Ph.D., the Company’s Chief Executive Officer, appointed Yanina Grant-Huerta as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective July 20, 2026.
On July 23, 2026, GE HealthCare named George Newcomb, Controller and Chief Accounting Officer, as interim Chief Financial Officer, effective August 14, 2026.
On July 21, 2026, James K. (Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the medical technology industry.
On July 23, 2026, Albertsons Companies, Inc. (the "Company") issued a press release announcing that Sharon McCollam, President and Chief Financial Officer, informed the Company that she has decided to retire later this year.
On July 18, 2026, Prof. Amnon Shashua, President and Chief Executive Officer of Mobileye Global Inc. (the “Company”) informed the Company’s Board of Directors (the “Board”) of his intention to step down as President and Chief Executive Officer upon the appointment of his successor.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Northfield Bancorp’s directors and executive officers ceased serving as directors and executive officers of Northfield Bancorp.
Vaughan R. Dozier, Jr., age 45, will become Chief Executive Officer of the Bank and Joseph A. “Drew” Painter, age 48, will become President of the Bank, each effective January 1, 2027.
On July 17, 2026, the board of directors (the “Board”) of Upland Software, Inc. (the “Company”) appointed Jennifer Simon to serve as Chief Financial Officer of the Company, effective as of August 17, 2026 (the “Effective Date”).
Mr. Stehlin resigned as the Chief Executive Officer of the Company (“CEO”), effective immediately following execution of the Agreement.
On July 21, 2026, Mr. Rozenbaum was appointed as the Interim CEO of the Company.
On July 20, 2026, the Board of Directors (the “Board”) of CrossAmerica GP LLC, the general partner (the “General Partner”) of CrossAmerica Partners LP (“CrossAmerica” or the “Partnership”), appointed Jonathan E. Benfield to serve as Chief Financial Officer of the General Partner, effective immediately.
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
Effective on July 17, 2026, Debra DeFelice no longer serves as Chief Financial Officer (“CFO”), Treasurer, and Executive Vice President of the Company.
The Board appointed Roberto Castro as interim CFO and interim Treasurer on July 20, 2026.
Maximilian Staedtler was appointed to serve as Chief Financial Officer of the Company, effective July 17, 2026.
Elliot Richmond resigned as the Chief Financial Officer of the Company, effective July 17, 2026.
Accordingly, on July 17, 2026, Lazar was appointed as the Chief Executive Officer of the Company.
Arturo Rodriguez’s position as the Company’s Chief Executive Officer terminated.
Joshua Feldman, the Company’s Chief Financial Officer, and the Company entered into a Transition and Separation Agreement (the “ Feldman Agreement ”), pursuant to which Mr. Feldman agreed to remain with the Company as its Chief Financial Officer through September 4, 2026.
On July 9, 2026, the Board appointed Nir Naor as the Company’s Executive Vice President, Chief Financial Officer, and Treasurer with an effective date on or about July 23, 2026.
Barbara Humpton will retire as Chief Executive Officer and as a director of the Company, effective on October 1, 2026
On July 20, 2026, the Board of Directors (the “Board”) of Lightwave Logic, Inc. (the “Company”) appointed Fred A. Graffam III as the Company’s Chief Financial Officer, effective immediately.
On July 16, 2026, the Board of Directors (the “Board”) of Kalaris Therapeutics, Inc. (the “Company”) appointed Liisa Bayko as Chief Financial Officer and Treasurer of the Company, effective as of July 20, 2026 (the “Effective Date”).
On July 15, 2026, Bunker Hill Mining Corp. (the “ Company ”) appointed Bradley Barnett, age 55, as the Company’s Chief Financial Officer, effective on July 15, 2026.
On July 17, 2026, Lindsay Corporation (the “Company”) announced that Sam Hinrichsen notified the Board of Directors of the Company of his intent to resign from his position as the Company’s Senior Vice President and Chief Financial Officer effective August 31, 2026 (the “Effective Date”).
the Company accepted the resignations or removals by court order of Lei Zhang as Chief Executive Officer and Executive Director
On June 29, 2026, Irina Veselinovic was further appointed Chief Financial Officer of the Company.
Mr. Guy Ofir voluntarily resigned from his positions as Chief Financial Officer, General Counsel, and Director of the Company, effective July 16, 2026.
Effective July 16, 2026, the Company appointed Mr. Uri Tadelis as its Chief Financial Officer.
Effective July 15, 2026, the Board of Directors of Destiny Media Technologies Inc. (the "Company") appointed Sharath Cherian as the Company's Chief Executive Officer and President.
Also effective July 15, 2026, Hyonmyong ("Hoch") Cho ceased serving as the Company's Interim Chief Executive Officer and will continue to serve as Chairman of the Board of Directors.
On July 10, 2026, the Board appointed Mr. Glashow, age 63, as Chief Executive Officer of the Company, effective immediately.
During Ms. Gessert’s leave, Hayden Brown, the Company’s President and Chief Executive Officer, will assume the role of the Company’s interim principal financial officer.
Effective July 14, 2026, Upwork Inc.’s, or the Company’s, Chief Financial Officer and principal financial officer, Erica Gessert, will take a temporary medical leave.
the Board also appointed Mr. Frank Pellegrino, the Company’s current Chief Financial Officer, Executive Vice President, Finance and Administration, as President and Chief Financial Officer of the Company, effective on the Transition Date.
the Board appointed Mr. Jasper B. Sanfilippo, Jr., the Company’s current Chief Operating Officer, President and Secretary, as Chief Executive Officer of the Company, effective on the Transition Date.
Effective July 13, 2026, Jeremy Daniel ceased serving as Chief Financial Officer and transitioned to a corporate accounting role with the Company.
Effective July 13, 2026, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed George O’Leary, age 63, as its part-time Interim Chief Financial Officer.
The executive officers who were removed were: Gerald F. Vinci, President, Joseph R. Brinkman, Vice President and Chief Financial Officer, and Herbert G. Hotchkiss, Vice President, General Counsel and Secretary.
On July 16, 2026, the Company announced that Glenn Reicin, the Company’s Chief Financial Officer, will be stepping down as the Company’s Chief Financial Officer effective as of July 16, 2026 to pursue other career opportunities.
On July 16, 2026, the Board of Directors of the Company appointed Stephen Mollichella, the Company’s Senior Vice President and Controller, as Interim Principal Financial Officer of the Company, effective as of July 16, 2026.
The Company’s Board of Directors has appointed Arun Kalra to succeed Ms. Meates as the Company’s Chief Financial Officer effective as of the Effective Date.
Helen Meates, Chief Financial Officer of PJT Partners Inc. (the “Company”), has informed the Company of her intention to step down from her role as Chief Financial Officer as of October 1, 2026 (the “Effective Date”).
On July 10, 2026, Sam Martin, Senior Vice President and Chief Financial Officer of Celldex Therapeutics, Inc. (the “Company”), notified the Company of his plans to retire effective on or about March 31, 2027.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.